NAPEPLD and neuropathy: Previous studies have demonstrated a significant increase in both mRNA and protein expression levels of cannabinoid 1 receptor, transient receptor potential vanilloid 1, and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in the DRGs of neuropathy rats during the development or maintenance of pain [24,25].